Trial to Evaluate the Hemostatic Effect of Lyostypt® Versus Surgicel® in Arterial Bypass Anastomosis

NCT00837954 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Vascular Diseases
Hemostasis

Interventions

DEVICE: Lyostypt® AND Surgicel®
DEVICE: Lyostypt®
PROCEDURE: Surgicel®

Sponsor

Aesculap AG